This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Egenesis, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Heja: Inventor Advancing Xenograft Research
Introduction
David Heja is an inventor based in Cambridge, Massachusetts. His work includes patented innovations involving genetically modified cells, tissues, organs, and animals intended to improve xenograft survival and tolerance. He is associated with eGenesis, Inc., and holds 2 patents.
Latest Patents
The supplied patent information describes an invention titled “Cells, Tissues, Organs, and Animals Having One or More Modified Genes for Enhanced Xenograft Survival and Tolerance.” The disclosure concerns modified genes intended to enhance the survival of transplanted biological materials and improve tolerance in xenograft applications. It also describes methods for making and using the modified cells, tissues, organs, and animals.
The two entries provided share the same title and description, so they appear to represent the same disclosed invention rather than two distinct patent summaries.
Career Highlights
Heja’s listed patent work focuses on genetic modifications with potential applications in xenotransplantation. The disclosed methods and biological materials address challenges associated with the survival and acceptance of xenografts.
Collaborations
Heja’s listed coworkers include Juliet Crabtree and Wenning Qin. His work is associated with eGenesis, Inc.
Conclusion
David Heja’s patent portfolio, as described in the supplied information, centers on modified biological materials designed to support xenograft survival and tolerance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile